You have 9 free searches left this month | for more free features.

Tianjin (1)

Advanced Malignancies (1)

Not yet recruiting (1)

phase 1 (1)

Innovent Biologics (Suzhou) Co. Ltd. (1)

ibi397 (1)

ibi397+rituximab (1)

ibi397+sintilimab (1)

drug (1)

Industry (1)

Interventional (1)

ibi397

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Tianjin, Tianjin, China

Tianjin Medical University Cancer Institute and Hospital

Feb 8, 2022